Reactions to START:REACTS

Affiliations

¹ Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.
² Rothman Orthopaedic Institute, Philadelphia, PA, USA.
³ MedStar Union Memorial Hospital, Baltimore, MD, USA.
⁴ Magna Graecia University, Catanzaro, Italy.
⁵ Johns Hopkins University, Baltimore, MD, USA.
⁶ The CORE Institute, Phoenix, AZ 18444, USA. Electronic address: michael.amini@thecoreinstitute.com.

Comment

Nikhil N Verma et al. Lancet. 2022.

. 2022 Nov 5;400(10363):1583.

doi: 10.1016/S0140-6736(22)01791-3.

¹ Midwest Orthopaedics at Rush, Rush University Medical Center, Chicago, IL, USA.
² Rothman Orthopaedic Institute, Philadelphia, PA, USA.
³ MedStar Union Memorial Hospital, Baltimore, MD, USA.
⁴ Magna Graecia University, Catanzaro, Italy.
⁵ Johns Hopkins University, Baltimore, MD, USA.
⁶ The CORE Institute, Phoenix, AZ 18444, USA. Electronic address: michael.amini@thecoreinstitute.com.

No abstract available

Comment in

Reactions to START:REACTS - Authors' reply.
Metcalfe A, Parsons H, Lawrence T, Drew S, Underwood M. Metcalfe A, et al. Lancet. 2022 Nov 5;400(10363):1583-1584. doi: 10.1016/S0140-6736(22)01799-8. Lancet. 2022. PMID: 36335968 No abstract available.

Subacromial balloon spacer for irreparable rotator cuff tears of the shoulder (START:REACTS): a group-sequential, double-blind, multicentre randomised controlled trial.
Metcalfe A, Parsons H, Parsons N, Brown J, Fox J, Gemperlé Mannion E, Haque A, Hutchinson C, Kearney R, Khan I, Lawrence T, Mason J, Stallard N, Underwood M, Drew S; START:REACTS team. Metcalfe A, et al. Lancet. 2022 May 21;399(10339):1954-1963. doi: 10.1016/S0140-6736(22)00652-3. Epub 2022 Apr 21. Lancet. 2022. PMID: 35461618 Clinical Trial.